Objectives

After participating in this educational activity, attendees should be able to:
1|Recognize the mechanisms of antibody-drug conjugates and the advantages of using these agents

2| Identify the mechanistic differences between trastuzumab deruxtecan and trastuzumab emtansine

3| Evaluate data for current FDA-approved indications for trastuzumab deruxtecan

4| Apply strategies for management of toxicities associated with trastuzumab deruxtecan

Presenter(s): 
Sabrina Pham, PharmD
PGY1 Pharmacy Resident
Baystate Medical Center
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Sabrina Pham, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
04/06/2026 - 2:00pm to 3:00pm EDT
Location: 
Hybrid
United States
See map: Google Maps
Add to calendar: 
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours
Please login or register to take this course.